Parkinson's disease and local atrophy in subcortical nuclei: Insight from shape analysis

Neurobiology of Aging

Volumn 36, Issue 1, 2015, Pages 424-433

  Nemmi, Federico ^a,b,d   Sabatini, Umberto ^c   Rascol, Olivier ^a,b   Péran, Patrice ^a,b  

^a CHU PURPAN   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Discrimination; Parkinson's disease; Shape analysis; T1 imaging

Indexed keywords

ADULT; ARTICLE; BRAIN CORTEX ATROPHY; BRAIN NUCLEUS; BRAIN SIZE; CAUDATE NUCLEUS; CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISCRIMINANT ANALYSIS; DISEASE MARKER; FEMALE; GRAY MATTER; HUMAN; MALE; MOTOR DYSFUNCTION; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PUTAMEN; STRUCTURE ANALYSIS; SUBCORTEX; SYMPTOM; TRACTOGRAPHY; VALIDATION PROCESS; AGED; ATROPHY; DIFFUSION WEIGHTED IMAGING; MIDDLE AGED; PATHOLOGY;

AGED; ATROPHY; CAUDATE NUCLEUS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GRAY MATTER; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PUTAMEN;

EID: 84920491691     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.07.010     Document Type: Article

References (59)

1. Alegret M., Junqué C., Pueyo R., Valldeoriola F., Vendrell P., Tolosa E., Mercader J.M. MRI atrophy parameters related to cognitive and motor impairment in Parkinson's disease. Neurologia 2001, 16:63-69.
2. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986, 9:357-381.
3. Anbeek P., Išgum I., van Kooij B.J., Mol C.P., Kersbergen K.J., Groenendaal F., Viergever M.A., de Vries L.S., Benders M.J. Automatic segmentation of eight tissue classes in neonatal brain MRI. PLoS One 2013, 8:e81895.
4. Apostolova L.G., Beyer M., Green A.E., Hwang K.S., Morra J.H., Chou Y.Y., Avedissian C., Aarsland D., Janvin C.C., Larsen J.P., Cummings J.L., Thompson P.M. Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov. Disord. 2010, 25:687-695.
5. Barnes J., Ourselin S., Fox N.C. Clinical application of measurement of hippocampal atrophy in degenerative dementias. Hippocampus 2009, 19:510-516.
6. Behrens T.E., Johansen-Berg H., Woolrich M.W., Smith S.M., Wheeler-Kingshott C.A., Boulby P.A., Barker G.J., Sillery E.L., Sheehan K., Ciccarelli O., Thompson A.J., Brady J.M., Matthews P.M. Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat. Neurosci. 2003, 6:750-757.
7. Bergman H., Deuschl G. Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov. Disord. 2002, 17(Suppl 3):S28-S40.
8. Boelmans K., Holst B., Hackius M., Finsterbusch J., Gerloff C., Fiehler J., Münchau A. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy. Mov. Disord. 2012, 27:421-427.
9. Brenneis C., Seppi K., Schocke M.F., Müller J., Luginger E., Bösch S., Löscher W.N., Büchel C., Poewe W., Wenning G.K. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov. Disord. 2003, 18:1132-1138.
10. Cherubini A., Péran P., Caltagirone C., Sabatini U., Spalletta G. Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured invivo using MRI. Neuroimage 2009, 48:29-36.
11. De Jong L.W., van der Hiele K., Veer I.M., Houwing J.J., Westendorp R.G., Bollen E.L., de Bruin P.W., Middelkoop H.A., van Buchem M.A., van der Grond J. Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain 2008, 131:3277-3285.
12. Del Tredici K., Rüb U., De Vos R.A., Bohl J.R., Braak H. Where does Parkinson disease pathology begin in the brain?. J.Neuropathol. Exp. Neurol. 2002, 61:413-426.
13. Derakhshan M., Caramanos Z., Giacomini P.S., Narayanan S., Maranzano J., Francis S.J., Arnold D.L., Collins D.L. Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis. Neuroimage 2010, 52:1261-1267.
14. Desikan R.S., Ségonne F., Fischl B., Quinn B.T., Dickerson B.C., Blacker D., Buckner R.L., Dale A.M., Maguire R.P., Hyman B.T., Albert M.S., Killiany R.J. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006, 31:968-980.
15. Douaud G., Gaura V., Ribeiro M.J., Lethimonnier F., Maroy R., Verny C., Krystkowiak P., Damier P., Bachoud-Levi A.C., Hantraye P., Remy P. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 2006, 32:1562-1575.
16. Eckert T., Sailer M., Kaufmann J., Schrader C., Peschel T., Bodammer N., Heinze H.J., Schoenfeld M.A. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 2004, 21:229-235.
17. Erickson K.I., Prakash R.S., Voss M.W., Chaddock L., Heo S., McLaren M., Pence B.D., Martin S.A., Vieira V.J., Woods J.A., McAuley E., Kramer A.F. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J.Neurosci. 2010, 30:5368-5375.
18. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
19. Giorgio A., De Stefano N. Clinical use of brain volumetry. J.Magn. Reson. Imaging 2013, 37:1-14.
20. Geng D.Y., Li Y.X., Zee C.S. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease. Neurosurgery 2006, 58:256-262. discussion 256-62.
21. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1988, 51:745-752.
22. Hayasaka S., Nichols T.E. Validating cluster size inference: random field and permutation methods. Neuroimage 2003, 20:2343-2356.
23. Hedman A.M., van Haren N.E., Schnack H.G., Kahn R.S., Hulshoff Pol H.E. Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies. Hum. Brain Mapp. 2012, 33:1987-2002.
24. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
25. Hua K., Zhang J., Wakana S., Jiang H., Li X., Reich D.S., Calabresi P.A., Pekar J.J., van Zijl P.C., Mori S. Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage 2008, 39:336-347.
26. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002, 17:825-841.
27. Jenkinson M., Beckmann C.F., Behrens T.E., Woolrich M.W., Smith S.M. FSL. Neuroimage 2012, 62:782-790.
28. Jenkinson M., Smith S. Aglobal optimisation method for robust affine registration of brain images. Med. Image Anal. 2001, 5:143-156.
29. Jeong J.W., Asano E., Brown E.C., Tiwari V.N., Chugani D.C., Chugani H.T. Automatic detection of primary motor areas using diffusion MRI tractography: comparison with functional MRI and electrical stimulation mapping. Epilepsia 2013, 54:1381-1390.
30. Kosta P., Argyropoulou M.I., Markoula S., Konitsiotis S. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease. J.Neurol. 2006, 253:26-32.
31. Lang A.E., Obeso J.A. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol. 2004, 3:309-316.
32. Lee S.H., Kim S.S., Tae W.S., Lee S.Y., Choi J.W., Koh S.B., Kwon D.Y. Regional volume analysis of the Parkinson disease brain in early disease stage: gray matter, white matter, striatum, and thalamus. AJNR Am. J. Neuroradiol. 2011, 32:682-687.
33. Litvan I., Bhatia K.P., Burn D.J., Goetz C.G., Lang A.E., McKeith I., Quinn N., Sethi K.D., Shults C., Wenning G.K. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov. Disord. 2003, 18:467-486. Movement Disorders Society Scientific Issues Committee.
34. Martin W.R., Wieler M., Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008, 70:1411-1417.
35. Menke R.A., Scholz J., Miller K.L., Deoni S., Jbabdi S., Matthews P.M., Zarei M. MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage 2009, 47:435-441.
36. Menke R.A., Szewczyk-Krolikowski K., Jbabdi S., Jenkinson M., Talbot K., Mackay C.E., Hu M. Comprehensive morphometry of subcortical grey matter structures in early-stage Parkinson's disease. Hum. Brain Mapp. 2013, 35:1681-1690.
37. Messina D., Cerasa A., Condino F., Arabia G., Novellino F., Salsone M., Morelli M., Lanza P.L., Quattrone A. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat. Disord. 2011, 17:172-176.
38. Meulenbroek O., Rijpkema M., Kessels R.P., Rikkert M.G., Fernández G. Autobiographical memory retrieval in patients with Alzheimer's disease. Neuroimage 2010, 53:331-340.
39. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2002, 15:1-25.
40. Nugent A.C., Luckenbaugh D.A., Wood S.E., Bogers W., Zarate C.A., Drevets W.C. Automated subcortical segmentation using FIRST: test-retest reliability, interscanner reliability, and comparison to manual segmentation. Hum. Brain Mapp. 2013, 34:2313-2329.
41. Pan P.L., Shi H.C., Zhong J.G., Xiao P.R., Shen Y., Wu L.J., Song Y.Y., He G.X., Li H.L. Gray matter atrophy in Parkinson's disease with dementia: evidence from meta-analysis of voxel-based morphometry studies. Neurol. Sci. 2013, 34:613-619.
42. Patenaude B., Smith S.M., Kennedy D.N., Jenkinson M. ABayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011, 56:907-922.
43. Peng X., Lin P., Zhang T., Wang J. Extreme learning machine-based classification of ADHD using brain structural MRI data. PLoS One 2013, 8:e79476.
44. Péran P., Cherubini A., Assogna F., Piras F., Quattrocchi C., Peppe A., Celsis P., Rascol O., Démonet J.F., Stefani A., Pierantozzi M., Pontieri F.E., Caltagirone C., Spalletta G., Sabatini U. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 2010, 133:3423-3433.
45. Pitcher T.L., Melzer T.R., Macaskill M.R., Graham C.F., Livingston L., Keenan R.J., Watts R., Dalrymple-Alford J.C., Anderson T.J. Reduced striatal volumes in Parkinson's disease: a magnetic resonance imaging study. Transl. Neurodegener. 2012, 1:17.
46. Rodriguez-Oroz M.C., Jahanshahi M., Krack P., Litvan I., Macias R., Bezard E., Obeso J.A. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol. 2009, 8:1128-1139.
47. Smith S.M., Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009, 44:83-98.
48. Smith Y., Villalba R. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Mov. Disord. 2008, 23(Suppl 3):S534-S547.
49. Sterling N.W., Du G., Lewis M.M., Dimaio C., Kong L., Eslinger P.J., Styner M., Huang X. Striatal shape in Parkinson's disease. Neurobiol. Aging 2013, 34:2510-2516.
50. Stoffers D., Sheldon S., Kuperman J.M., Goldstein J., Corey-Bloom J., Aron A.R. Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology 2010, 74:1208-1216.
51. Summerfield C., Junqué C., Tolosa E., Salgado-Pineda P., Gómez-Ansón B., Martí M.J., Pastor P., Ramírez-Ruíz B., Mercader J. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch. Neurol. 2005, 62:281-285.
52. Tessitore A., Amboni M., Cirillo G., Corbo D., Picillo M., Russo A., Vitale C., Santangelo G., Erro R., Cirillo M., Esposito F., Barone P., Tedeschi G. Regional gray matter atrophy in patients with Parkinson disease and freezing of gait. AJNR Am. J. Neuroradiol. 2012, 33:1804-1809.
53. Tziortzi A.C., Haber S.N., Searle G.E., Tsoumpas C., Long C.J., Shotbolt P., Douaud G., Jbabdi S., Behrens T.E., Rabiner E.A., Jenkinson M., Gunn R.N. Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography. Cereb. Cortex 2013, 24:1165-1177.
54. Uitti R.J., Baba Y., Whaley N.R., Wszolek Z.K., Putzke J.D. Parkinson disease: handedness predicts asymmetry. Neurology 2005, 64:1925-1930.
55. Vandenberghe R., Nelissen N., Salmon E., Ivanoiu A., Hasselbalch S., Andersen A., Korner A., Minthon L., Brooks D.J., Van Laere K., Dupont P. Binary classification of 18F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI. Neuroimage 2013, 64:517-525.
56. Wierenga L., Langen M., Ambrosino S., van Dijk S., Oranje B., Durston S. Typical development of basal ganglia, hippocampus, amygdala and cerebellum from age 7 to 24. Neuroimage 2014, 96:67-72.
57. Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 2001, 20:45-57.
58. Zarei M., Patenaude B., Damoiseaux J., Morgese C., Smith S., Matthews P.M., Barkhof F., Rombouts S.A., Sanz-Arigita E., Jenkinson M. Combining shape and connectivity analysis: an MRI study of thalamic degeneration in Alzheimer's disease. Neuroimage 2010, 49:1-8.
59. Zarei M., Ibarretxe-Bilbao N., Compta Y., Hough M., Junque C., Bargallo N., Tolosa E., Martí M.J. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J.Neurol. Neurosurg. Psychiatry 2013, 84:875-881.